Followers | 256 |
Posts | 18838 |
Boards Moderated | 3 |
Alias Born | 12/02/2014 |
Monday, April 22, 2024 12:54:21 PM
The $10.8m estimate revenue is based on an investment of $10m. He commented on this in Dec. 2023?
DENG had to know about this before he made the Revenue prediction?
Because the company still needs to raise US$10 million to participate in distribution investment in the Chinese film market?
What happens if they don't get the $10 million Investment/Line of Credit?
And as it is presented in Tweets it is not an Investment but a Line of Credit?
@ABIntlGroup Jan 19
$ABQQ Investors in the $10 million credit line are allowed to use it for http://abqq.tv marketing. This builds on investors' interest in the streaming service's partnership with the owners of more than 1,000 movie rights.
@ABIntlGroupJan 2
$ABQQ New Year’s progress, can’t wait to share with you that it will be confirmed that the company has generated US$2.1 million in revenue from the Chinese film market alone this January SO they can't record this Revenue currently because "The box office settlement will take up to 9 months to complete, and the income of investment companies outside China must go through legal transfers to outside before they can be included in operating income.
So none of this revenue is from is from the Chinese film market?
REVENUE
Copyrights and license $885,289
Theatre admissions and food and beverage sales $199,364
Consulting services $102,347
Total revenue $1,187,000
https://www.otcmarkets.com/filing/html?id=17449607&guid=xmQ-kHXtV1mldth
And here in Dec. 2023 DENG has statedn "It’s received an investment credit line of US$10 million will be added to working capital from some investors.
$ABQQ: Because AB won’t use equity to raise funds, the shares are not diluted and there is no need to R/S. It’s received an investment credit line of US$10 million will be added to working capital from some investors. Investors are optimistic about AB's unique businesses,…
— ABQQ (@ABIntlGroup) December 5, 2023
Recent ABQQ News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 08:05:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 08:04:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 06:08:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 05:57:38 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 07:45:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 05:12:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 04:33:38 PM
- US Airforce Contract Awarded to Epazz, Inc. (OTC Pink: EPAZ) • InvestorsHub NewsWire • 12/14/2023 11:48:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2023 04:35:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/01/2023 09:47:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 09:19:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/30/2023 08:55:58 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/29/2023 08:35:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 04:24:58 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/18/2023 05:57:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2023 03:53:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2023 09:24:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/13/2023 09:29:56 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM